FOUNDED IN OCTOBER 2018 BY PROFESSOR BENGT SAMUELSSON, A NOBEL PRICE LAUREATE, PROFESSOR JAN-CHRISTER JANSON, DR. GU MING AND HER TEAM. ENLITISA IS A CHINESE-SWEDISH COMPANY FOCUSED ON DEVELOPING TREATMENTS FOR INFLAMMATORY AND FIBROTIC DISEASES WITH HIGH UNMET MEDICAL NEED

Improving lives for patients with serious inflammatory and fibrotic diseases

EnliTISA

Original research R & D pipeline UP818 Montelukast sodium

Our team


Anders Kärnell

Anders Kärnell


Anders Kärnell

Stephen McNeeney:IP attorney

Stephen McNeeney:IP attorney

Potter Clarkson Intellectual Property Office, UK


· Has cooperated with the company for 5 and a half years, responsible for the company's intellectual property strategy construction and international PCT application, completed 12 international invention patent applications, 2 Chinese patent authorizations, and 1 US patent authorization. IP due diligence and negotiation to support Chinese and overseas transactions · Supported over 70 clients in IP due diligence and negotiation of intercontinental licensing transactions


The world's leading original innovative 
drug enterprise for inflammation and injury

Welcome to join us